Narrow-Band UVB Therapy

NB-UVB Basics - The Healing Light

• A specific type of phototherapy utilizing a narrow range of UVB light.
• Mechanism: Primarily immunomodulatory; induces apoptosis of pathogenic T-lymphocytes, alters cytokine profiles (e.g., ↓IL-17, ↑IL-10).
• Advantages: Greater efficacy and lower erythemogenic potential compared to broadband UVB.
• Preferred for psoriasis, vitiligo, atopic dermatitis.

⭐ NB-UVB primarily emits light in the 311-313 nm range, considered the most effective and safest part of the UVB spectrum for treating skin diseases.

NB-UVB Indications - Skin's Best Friend

• Psoriasis: Chronic plaque, guttate (second-line).
• Vitiligo: Generalized, especially facial/truncal.
• Atopic Dermatitis: Moderate to severe, chronic.
• Mycosis Fungoides: Early-stage (patch/plaque).
• Polymorphic Light Eruption (PLE): Prophylaxis.
• Chronic Urticaria: Symptomatic relief.
• Lichen Planus: Generalized, pruritic.
• Pruritus: Uremic, cholestatic, HIV-associated.

⭐ For vitiligo, NB-UVB is often considered a first-line treatment, especially for generalized disease.

📌 Mnemonic: "People Value All Medical Professionals Carefully Listening Patiently" (Psoriasis, Vitiligo, Atopic dermatitis, Mycosis fungoides, PLE, Chronic urticaria, Lichen planus, Pruritus).

NB-UVB Cautions - Safety First Rays

• Absolute Contraindications:
  • Lupus erythematosus
  • Dermatomyositis
  • History of skin cancer (melanoma, squamous cell carcinoma)
  • Genetic photosensitivity disorders (e.g., Xeroderma Pigmentosum)
  • Pemphigus / Pemphigoid (can be exacerbated)
  • Concurrent use of photosensitizing drugs (e.g., psoralens, retinoids, tetracyclines, thiazides) without specific protocols.
• Relative Contraindications/Cautions:
  • History of multiple non-melanoma skin cancers
  • Severe photodamage
  • Cataracts or aphakia (unless eyes are protected)
  • Immunosuppression (e.g., post-transplant)
  • Children < 10 years (use with caution)
  • Pregnancy (generally considered safe, but discuss risks)

⭐ Patients with a history of melanoma or conditions like Xeroderma Pigmentosum are absolute contraindications for NB-UVB therapy.

⚠️ Always shield eyes, genitalia, and unaffected skin. Monitor for erythema, blistering, and long-term carcinogenesis risk. 📌 Skin Cancer Always Makes Phototherapy Scary (SCAMPS - Skin Cancer, Autoimmune, Medications, Photosensitivity, Severe damage).

NB-UVB Protocol - Dose & Delivery

• Initial Dose:
  • Determined by Minimal Erythema Dose (MED) test (50-70% of MED).
  • Or, by skin phototype (e.g., Fitzpatrick I-II: ~0.2 J/cm²; III-IV: ~0.3 J/cm²).
• Dose Escalation:
  • Gradual increase, typically 10-20% per treatment, if no adverse erythema.
  • Adjust based on skin reaction: maintain, decrease, or skip if significant redness.
• Maximum Dose & Duration:
  • Individualized; aim for therapeutic effect without burns. Monitor cumulative exposure.

⭐ Treatment frequency is typically 2-3 times per week, with non-consecutive days to allow skin recovery.

NB-UVB Reactions - Sunburn's Cousins

• Acute Reactions (Sunburn-like):
  • Erythema: Most common, dose-dependent. Mild cases resolve in 24 hrs.
  • Pruritus (itching): Common; manage with emollients, antihistamines.
  • Xerosis (dry skin): Frequent; emphasize regular moisturizer use.
  • Blistering: Rare, indicates significant overexposure; adjust dose.
  • Herpes simplex reactivation: Uncommon; consider prophylaxis if history.
• Chronic Reactions:
  • Photoaging: Premature skin aging (wrinkles, lentigines) with long-term exposure.
  • Photocarcinogenesis: Theoretical NMSC risk. Higher with prior PUVA/immunosuppression. Regular skin surveillance vital.

⭐ The most common acute side effect of NB-UVB is asymptomatic erythema (mild sunburn), which usually resolves within 24 hours.

High‑Yield Points - ⚡ Biggest Takeaways

• NB-UVB uses a peak wavelength of 311 nm (311-313 nm range).
• Main action: immunomodulation via T-cell apoptosis and cytokine alteration.
• Prime indications: psoriasis (widespread), vitiligo, atopic dermatitis, early mycosis fungoides.
• Superior to BB-UVB: ↑ efficacy for psoriasis, ↓ erythema, ↓ cumulative dose.
• Treatment protocol: 2-3 sessions/week; initial dose ~70% MED or fixed low dose.
• Common acute effects: erythema, pruritus; chronic: photoaging, (lower) skin cancer risk.
• Avoid in xeroderma pigmentosum, SLE, history of melanoma or multiple skin cancers.